Forsta Ap Fonden Moderna, Inc. Transaction History

Forsta Ap Fonden

$11.2 Billion
Q2 2024

A detailed history of Forsta Ap Fonden transactions in Moderna, Inc. stock. As of the latest transaction made, Forsta Ap Fonden holds 60,500 shares of MRNA stock, worth $4.04 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

60,500

Previous 66,600 9.16%

Holding current value

$4.04 Million

Previous $7.1 Million 1.24%

% of portfolio

0.06%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$101.21 - $166.61 $617,381 - $1.02 Million	-6,100 Reduced 9.16%	60,500 $7.18 Million
Q1 2024 May 07, 2024	BUY	$85.37 - $115.44 $597,590 - $808,080	7,000 Added 11.74%	66,600 $7.1 Million
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $215,481 - $323,733	-3,100 Reduced 4.94%	59,600 $5.93 Million
Q3 2023 Oct 25, 2023	BUY	$96.41 - $126.61 $28,923 - $37,983	300 Added 0.48%	62,700 $6.48 Million
Q2 2023 Aug 03, 2023	BUY	$118.5 - $160.53 $35,550 - $48,159	300 Added 0.48%	62,400 $7.58 Million
Q1 2023 Apr 21, 2023	SELL	$135.66 - $197.02 $7.33 Million - $10.6 Million	-54,000 Reduced 46.51%	62,100 $9.54 Million
Q4 2022 Feb 02, 2023	BUY	$118.38 - $210.04 $2.91 Million - $5.17 Million	24,600 Added 26.89%	116,100 $20.9 Million
Q3 2022 Oct 17, 2022	BUY	$118.07 - $194.18 $3.59 Million - $5.9 Million	30,400 Added 49.75%	91,500 $10.8 Million
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $2.55 Million - $3.85 Million	-21,800 Reduced 26.3%	61,100 $8.73 Million
Q1 2022 May 09, 2022	BUY	$126.46 - $235.05 $101,168 - $188,040	800 Added 0.97%	82,900 $14.3 Million
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $1.15 Million - $1.88 Million	5,100 Added 6.62%	82,100 $20.9 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $155,330 - $339,129	700 Added 0.92%	77,000 $29.6 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $2.77 Million - $5.01 Million	21,300 Added 38.73%	76,300 $17.9 Million
Q1 2021 May 11, 2021	BUY	$109.18 - $185.98 $600,490 - $1.02 Million	5,500 Added 11.11%	55,000 $7.2 Million
Q4 2020 Feb 09, 2021	SELL	$65.74 - $169.86 $322,126 - $832,314	-4,900 Reduced 9.01%	49,500 $5.17 Million
Q3 2020 Feb 19, 2021	BUY	$54.34 - $94.85 $2.96 Million - $5.16 Million	54,400 New	54,400 $3.85 Million
Q3 2020 Oct 22, 2020	SELL	$54.34 - $94.85 $2.03 Million - $3.54 Million	-37,300 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$29.67 - $80.0 $1.11 Million - $2.98 Million	37,300 New	37,300 $2.4 Million

Others Institutions Holding MRNA

# of Institutions

1,114

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $26.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account